The study has implications for practice, based on the findings that the hyperinvasive approach was most beneficial for patients who were resuscitated for more than 45 minutes and that, among patients who were resuscitated for a shorter time, the number of neurologically intact survivors was similar in both groups, Blohlávek said.
"Timely transport to a hospital and treatment with ECMO should be considered for patients whose hearts do not regain spontaneous activity with standard advanced cardiac life support," Blohlávek said. "However, this may be viable only in circumstances where there is absolutely optimal prehospital care, including the ability to have a bystander perform chest compressions at the scene of the arrest with direction via telephone from the emergency dispatch center, and the ability to quickly transport the patient to a dedicated cardiac center where highly trained specialists are available."
Ad Statistics
Times Displayed: 47004
Times Visited: 1430 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
The study was funded by the Ministry of Health of the Czech Republic.
Blohlávek will be available to the media in a virtual press conference on Monday, May 17, at 12:15 p.m. ET / 16:15 UTC.
Blohlávek will present the study, "Hyperinvasive Approach In Refractory Out-of-hospital Cardiac Arrest: An Open-label Randomized Controlled Trial. Prague OHCA Study" on Monday, May 17, at 10:45 a.m. ET / 14:45 UTC, virtually.
ACC.21 will take place May 15-17 virtually, bringing together cardiologists and cardiovascular specialists from around the world to share the newest discoveries in treatment and prevention.
About ACC
The American College of Cardiology envisions a world where innovation and knowledge optimize cardiovascular care and outcomes. As the professional home for the entire cardiovascular care team, the mission of the College and its 54,000 members is to transform cardiovascular care and to improve heart health. The ACC bestows credentials upon cardiovascular professionals who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. The College also provides professional medical education, disseminates cardiovascular research through its world-renowned JACC Journals, operates national registries to measure and improve care, and offers cardiovascular accreditation to hospitals and institutions.
Back to HCB News
